Public/private partnerships for prescription drug coverage: Policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the medicare prescription drug program in the United States

Milbank Quarterly

Volumn 85, Issue 3, 2007, Pages 469-498

  Pomey, Marie Pascale ^a,b,c   Forest, Pierre Gerlier ^d   Palley, Howard A ^e,f,g   Martin, Elisabeth ^d,h  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Groupe de Recherche Interdisciplinaire En Santè

^c Pierre Elliott Trudeau Foundation

^d UNIVERSITÉ LAVAL   (Canada)

^e School Social Work

^f UNIVERSITY OF MARYLAND   (United States)

^g HEALTH CANADA   (Canada)

^h Health Care Reforms in Canada

Author keywords

Drug insurance; Health care reform; Medicare; Quebec

Indexed keywords

CANADA; COMPARATIVE STUDY; COOPERATION; DRUG COST; HEALTH INSURANCE; HUMAN; INSURANCE; MANAGEMENT; MEDICARE; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PUBLIC HEALTH; REVIEW; UNITED STATES;

COOPERATIVE BEHAVIOR; DRUG COSTS; HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; MEDICARE; NATIONAL HEALTH PROGRAMS; OUTCOME ASSESSMENT (HEALTH CARE); POLICY MAKING; PRIVATE SECTOR; PUBLIC SECTOR; QUEBEC; UNITED STATES; UNIVERSAL COVERAGE;

EID: 34548129151     PISSN: 0887378X     EISSN: 14680009     Source Type: Journal    
DOI: 10.1111/j.1468-0009.2007.00496.x     Document Type: Review

References (57)

1. Angell, M. 2005. The Truth about the Drug Companies. New York : Random House.
2. Atlas, R.F. 2004. The Role of PBMs in Implementing the Medicare Prescription Drug Benefit. Health Affairs, Web Exclusive, October 28.
3. Brook, R.H., J.E. Ware, W.H. Rogers, E.B. Keeler, A.R. Davies, C.D. Sherbourne, G.A. Goldberg, K.M. Lohr, P. Camp, and J.P. Newhouse. 1984. The Effect of Coinsurance on the Health of Adults. Santa Monica, Calif RAND Corporation.
4. Canada Health Action. 1997. Directions for a Pharmaceutical Policy in Canada. Available at http://www.hc-sc.gc.ca/hcs-sss/pubs/care-soins/1997-nfoh- fnss-v2/legacy_heritage7_e.html (accessed April 7, 2007).
5. Canadian Institute for Health Information. 2006. Drug Expenditures in Canada 1985-2005. Available at http://secure.cihi.ca/cihiweb/dispPage.jsp? cw_page=AR_80_E (accessed January 24, 2007).
6. Center for Public Integrity. 2005. Drug Lobby Second to None: How the Pharmaceutical Industry Gets Its Way in Washington. Available at http://www.publicintegrity.org/rx/report.aspx?aid=723 (accessed March 27, 2007).
7. Center for Public Integrity. 2007. Spending on Lobby Thrives. Available at http://www.publicintegrity.org/rx/report.aspx?aid=823 (accessed April 4, 2007).
8. Center for Responsive Politics. 2004. Pharmaceuticals/Health Products: Top Contributors to Federal Candidates and Parties, 2004 Election Cycle. Available at http://www.opensecrets.org/industries/contrib.asp?Ind= H04&Cycle=2004 (accessed March 27, 2007).
9. Drinkard, J., and W.M. Welch. 2003. AARP Accused of Conflict of Interest. USA Today, November 20, available at http://www.usatoday.com/news/washington/ 2003-11-20-aarp-protest_x.htm (accessed June 14, 2007).
10. Foster, R.S. 2004. Actuary in the Hot Seat. Contingencies, November/December. Available at http://www.contingencies.org/novdec04/ coverstory.pdf (accessed March 21, 2006).
11. Fuchs, V.R., and E.J. Emanuel. 2005. Health Care Reform: Why? What? When? Health Affairs 24 (6 1399 1414.
12. Glied, S. 1997. Chronic Conditions: Why Health Reform Fails. Cambridge, Mass Harvard University Press.
13. Government Accountability Office (GAO). 2006. Medicare Part D. Prescription Drug Plan Sponsor Call Center Responses Were Prompt, but Not Consistently Accurate and Complete. Available at http://www.gao.gov/new.items/ d06710.pdf (accessed March 27, 2007).
14. Haislmaier, E.F. 2005. Weird Science: Projecting the Effects of Medicare's Odd Drug Benefit Design. The Heritage Foundation Webmemo 674. Available at http://www.heritage.org/research/healthcare/wm674.cfm (accessed March 27, 2007).
15. Hanoch, Y., and T. Rice. 2006. Can Limiting Choice Increase Social Welfare? The Elderly and Health Insurance. The Milbank Quarterly 84 (1 37 73.
16. Health Policy Alternatives, Inc. 2003. Prescription Drug Coverage for Medicare Beneficiaries: A Summary of Medicare Prescription Drug, Improvement and Modernization Act of 2003. Menlo Park, Calif Henry J. Kaiser Family Foundation.
17. Hollis, A., and S. Law. 2004. A National Formulary for Canada. Canadian Public Policy - Analyse de Politiques 30 (4 445 52.
18. Hurley, J., and S. Morgan. 2004. US Medicare Reform: Why Drug Companies and Private Insurers Are Smiling. Canadian Medical Association Journal 170 (4 461 62.
19. IMS Health Canada. 2007. Canada Internet Pharmacy Sales to the United States Down 50% in 2006. Available at http://www.imshealthcanada.com/vgn/images/ portal/cit_40000873/7/25/80533297IMS%20Release%20Final%20English.pdf (accessed March 29, 2007).
20. Iyengar, S.S., and W. Jiang. 2005. The Psychological Costs of Ever Increasing Choice: A Fallback to the Sure Bet. Available at http://www.reish. com/publications/pdf/psychcosts.pdf (accessed March 29, 2007).
21. Kaiser Family Foundation. 2006a. Fact Sheet on Low-Income Assistance under the Medicare Drug Benefit. Available at http://www.kff.org/medicare/ upload/7327.pdf (accessed March 29, 2007).
22. Kaiser Family Foundation. 2006b. Seniors and the Medicare Prescription Drug Benefit. Available at http://www.kff.org/kaiserpolls/upload/7604.pdf (accessed March 21, 2007).
23. Kaiser Family Foundation. 2007. Medicare at a Glance - Fact Sheet. Available at http://www.kff.org/medicare/upload/1066-10.pdf (accessed March 21, 2007).
24. Kaiser Family Foundation/Harvard School of Public Health. 2004. Views of the New Medicare Drug Law: A Survey of People on Medicare. Available at http://www.kff.org/medicare/pomr081004pkg.cfm (accessed March 21, 2007).
25. Kingdon, J.W. 1995. Agendas, Alternatives, and Public Policies. New York : HarperCollins.
26. L'expansion.com. 2005. La France un petit peu moins accro aux antibiotiques (October 18). Available at http://www.lexpansion.com/PID/8309. html?Action=A&ArticleId=135736 (accessed November 29, 2006).
27. Maio, V., L. Pizzi, A.R. Roumm, J. Clarke, N. Goldfarb, D.B. Nash, D. Chess, and M. Maclure. 2005. Pharmacy Utilization and the Medicare Modernization Act. The Milbank Quarterly 83 (1 101 47.
28. Majone, G. 1975. The Feasibility of Social Policies. Policy Sciences 6 : 49 69.
29. Marmor, T.R. 1994. Understanding Health Care Reform. New Haven, Conn Yale University Press.
30. Marmor, T.R. 2000. The Politics of Medicare. New York : A. de Gruyter.
31. Marmor, T.R., R. Freeman, and K. Okma. 2005. Comparative Perspectives and Policy Learning in the World of Health Care. Journal of Comparative Policy Analysis 7 (4 331 48.
32. Mays, J., M. Brenner, T. Neuman, J. Cubanski, and G. Claxton. 2004. Estimates of Medicare Beneficiaries' Out-of-Pocket Drug Spending in 2006: Modeling the Impact of the MMA. Menlo Park, Calif Henry J. Kaiser Family Foundation.
33. Ministère de la Santé et des Services Sociaux. 2007. Lancement de la politique québécoise du médicament. Available at http://communiques.gouv.qc.ca/gouvqc/communiques/GPQF/Fevrier2007/ 01/c3690.html (accessed March 21, 2007).
34. Mintzberg, H. 2006. Patent Nonsense: Evidence Tells of an Industry Out of Social Control. Canadian Medical Association Journal 175 (4 374 76.
35. Morgan, S. 2004. Prescription Drugs: Sources of Variation in Provincial Drug Spending. Canadian Medical Association Journal 170 (3 329 30.
36. Morgan, S., K. Bassett, and B. Mintzes. 2004a. An Outcomes-Based Approach to Decisions about Drug Coverage Policies in British Columbia. Psychiatric Services 55 (11 1230 32.
37. Morgan, S., K. Bassett, and B. Mintzes. 2004b. Outcomes-Based Drug Coverage in British Columbia. Health Affairs 23 (3 269 76.
38. Oberlander, J. 2003. The Politics of Health Reform: Why Do Bad Things Happen to Good Plans? Health Affairs Web Special, August 27, W3-391 to W3-404. Available at http://medicine.ucsf.edu/greenwall/Oberlander.pdf (accessed June 15, 2007).
39. Oliver, T.R., P.R. Lee, and H.L. Lipton. 2004. A Political History of Medicare and Prescription Drug Coverage. The Milbank Quarterly 82 (2 283 354.
40. Organization for Economic Co-Operation and Development (OECD). 2006. OECD Health Data 2006. Available at http://www.oecd.org/dataoecd/20/51/37622205.xls (accessed April 11, 2007).
41. Pear, R. 2005a. Drug Cost Estimate Is Raised. New York Times, March 5. Available at http://www.nytimes.com/2005/03/05/politics/05budget.html?ex= 1180497600&en=e9aa0ed0da6d0d98&ei=5070# (accessed June 14, 2007).
42. Pear, R. 2005b. Medicare Will Revise Guide to New Benefits for 2006. New York Times, May 22. Available at http://www.nytimes.com/2005/05/22/politics/ 22medicare.html?ex=1181966400&en=4d223744d6966770&ei=5070 (accessed June 14, 2007).
43. Pear, R. 2006. Administration Opposes Democrats' Plan for Negotiating Medicare Drug Prices. New York Times, November 13. Available at http://www.nytimes.com/2006/11/13/washington/13medicare.html?ex= 1180497600&en=882628f6d037f5c8&ei=5070 (accessed June 14, 2007).
44. Pratte, A. 2007. Le ménage de la pharmacie. La Presse, February 4, p. A16.
45. Price Waterhouse Coopers. 2006. Significance of the Coverage Gap under Medicare Part D, Report Commissioned by the Health Leadership Council. Available at http://www.hlc.org/HLC_Coverage_Gap_Research_Report_FINAL.pdf (accessed January 25, 2007).
46. Québec, Comité d'experts sur l'assurance- médicaments. 1996. L'assurance-médicaments: Des voies de solution. Québec : Ministère de la Santé et des Services Sociaux.
47. Rancourt, C., J. Moisan, L. Baillargeon, R. Verrault, D. Laurin, and J-P. Grégoire. 2004. Potentially Inappropriate Prescriptions for Older Patients in Long-Term Care. BMC Geriatrics 4 (9 1 9.
48. Régie de l'assurance maladie du Québec (RAMQ). 2006. Available at http://www.prod.ramq.gouv.qc.ca/IST/CD/CDF_DifsnInfoStats/C- DF1_CnsulInfoStatsCNC_iut/DifsnInfoStats.aspx?LANGUE=en-CA&ETAPE_COUR=2 (accessed March 28, 2007).
49. Reinharz, D., L. Rousseau, and S. Rheault. 1999. La place du médicament dans le système de santé du Québec. In Le système de santé québécois: Un modèle en transformation, edited by C. Bégin, P. Bergeron, P-G. Forest, and V. Lemieux, 149 67. Montreal : Presses de l'Université de Montréal.
50. Russell Chaddock, G. 2003. Seniors' Old Friend Turns Foe, for Some. Christian Science Monitor, November 21, 95 (250 3.
51. Santé et Services sociaux du Québec. 2004. Pharmaceutical Policy Consultation Paper. Available at http://publications.msss.gouv.qc.ca/ acrobat/f/documentation/2004/04-708-04A.pdf (accessed January 25, 2007).
52. Statistics Canada. 2006. The Daily: Canada's Population by Age and Sex. Available at http://www.statcan.ca/Daily/English/061026/d061026b.htm (accessed April 4, 2007).
53. Strunk, B.C., and P.B. Ginsburg. 2003. Tracking Health Care Costs: Trends Slow in First Half of 2003. Data Bulletin (Center for Studying Health System Change) 26 : 1 2. Available at http://hschange.org/CONTENT/633/?topic=topic01 (accessed March 18, 2007).
54. Stuart, B., B.A. Briesacher, D.G. Shea, B. Cooper, F.S. Baysac, and M.R. Limcangco. 2005. Riding the Rollercoaster: The Ups and Downs in Out-Of-Pocket Spending under the Standard Medicare Drug Benefit. Health Affairs 24 (4 1022 32.
55. Tamblyn, R., R. Laprise, J.A. Hanley, M. Abrahamowicz, S. Scott, N. Mayo, J. Hurley, R. Grad, E. Latimer, R. Perreault, P. McLeod, A. Huang, P. Larochelle, and L. Mallet. 2001. Adverse Events Associated with Prescription Drug Cost-Sharing among Poor and Elderly Persons. JAMA 285 (4 421 29.
56. URAC. 2006. Issue Brief (October). Available at http://www.urac.org/ savedfiles/URACoctoberv5HighRes.pdf (accessed May 22, 2007).
57. Welch, W.M. 2004. Tauzin Switches Sides from Drug Industry Overseer to Lobbyist. USA Today, December 15, 4B. Available at http://www.usatoday.com/ money/industries/health/drugs/2004-12-15-drugs-usat_x.htm (accessed June 14, 2007).